REMStar Auto With C-Flex - In-Laboratory Performance v. Conventionally Titrated CPAP Therapy: Performances and Preferences
Obstructive Sleep Apnoea Hypopnoea Syndrome
About this trial
This is an interventional treatment trial for Obstructive Sleep Apnoea Hypopnoea Syndrome focused on measuring OSAHS and REMStar Auto with C-Flex
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 Primary medical diagnosis Obstructive Sleep Apnea / Hypopnea Syndrome AHI ≥ 15 events•hr-1 of sleep Ability to provide consent Successful completion of a conventional CPAP titration in a sleep laboratory under polysomnographic conditions (success defined by reduction of AHI to < 5•hr-1 during therapeutic portion of study, in supine position and in REM and NREM sleep state). Exclusion Criteria: Patients who are medically complicated or who are medically unstable. Patients who have been on chronic CPAP or BiPAP therapy or require oxygen therapy. Patients with respiratory failure or respiratory insufficiency or who have elevated arterial carbon dioxide levels while awake. Patients who have had surgery of the upper airway, nose, sinus, or middle ear within the previous 90 days. Patients with non-OSA sleep disorders. Patients in whom PAP therapy is otherwise medically contraindicated.
Sites / Locations
- UBC Sleep Disorder Program and Sleep Lab, UBC Hospital